Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands.

Maartje S JacobsM W J van LeentR G TielemanF G A JansmanQ CaoMaarten Jacobus PostmaM van Hulst

Published in: Journal of medical economics (2017)

Dabigatran treatment was as a predictor for lower cardiology costs and lower total hospital care costs in AF patients that initiated oral anticoagulation.

Keyphrases

atrial fibrillation
healthcare
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
palliative care
venous thromboembolism
health insurance
acute care
emergency department
quality improvement
thoracic surgery
combination therapy
replacement therapy
smoking cessation